From: Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells
Treatment | Fold change | ||||
---|---|---|---|---|---|
MUC2 | hsp70 | Cox-1 | Cox-2 | Cox-1/Cox-2 | |
Blank | 0.24 ± 0.02 | 0.18 ± 0.01 | 0.40 ± 0.01 | 1.18 ± 0.05 | 0.34 ± 0.02 |
 LPS | 0.37 ± 0.01 | 2.10 ± 0.13* | 0.21 ± 0.02*** | 14.77 ± 0.63* | 0.01 ± 0.001 |
 Lp9 | 1.49 ± 0.16* | 0.97 ± 0.03* | 0.61 ± 0.04*** | 0.20 ± 0.01 | 3.06 ± 0.35* |
 Lp91 | 0.54 ± 0.01 | 0.73 ± 0.02* | 1.26 ± 0.02* | 0.75 ± 0.0 | 1.68 ± 0.03 |
 Lp5276 | 2.96 ± 0.19* | 1.08 ± 0.05* | 1.10 ± 0.07* | 0.17 ± 0.00 | 6.47 ± 0.41* |
Pre-treatment with probiotics prior to LPS stimulation | |||||
 Lp9 | 3.30 ± 0.16* | 1.78 ± 0.07* | 1.12 ± 0.06* | 0.19 ± 0.01 | 5.92 ± 0.63* |
 Lp91 | 3.70 ± 0.39* | 1.08 ± 0.03* | 1.04 ± 0.03* | 0.16 ± 0.01 | 6.51 ± 0.22* |
 Lp5276 | 4.33 ± 0.72* | 1.36 ± 0.04* | 0.77 ± 0.07* | 0.07 ± 0.01 | 11.21 ± 2.43* |
Co-culture treatment with probiotics and LPS | |||||
 Lp9 | 2.57 ± 0.08* | 1.58 ± 0.12* | 1.44 ± 0.15* | 0.38 ± 0.01 | 3.78 ± 0.30* |
 Lp91 | 1.26 ± 0.05** | 0.76 ± 0.01* | 1.83 ± 0.04* | 0.42 ± 0.01 | 4.36 ± 0.01* |
 Lp5276 | 5.59 ± 0.21* | 1.98 ± 0.05* | 1.15 ± 0.01* | 0.25 ± 0.01 | 4.60 ± 0.14* |
Post-probiotic treatment after LPS stimulation | |||||
 Post-Lp9 | 0.37 ± 0.05 | 1.09 ± 0.12* | 0.20 ± 0.00*** | 17.87 ± 3.08* | 0.01 ± 0.002 |
 Post-Lp91 | 0.43 ± 0.03 | 1.20 ± 0.18* | 0.28 ± 0.04 | 15.98 ± 2.74* | 0.02 ± 0.01 |
 Post-Lp5276 | 0.29 ± 0.01 | 1.52 ± 0.14* | 0.16 ± 0.01** | 14.05 ± 1.07* | 0.01 ± 0.002 |